These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22878786)

  • 21. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
    Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
    Kooby DA; Lad NL; Squires MH; Maithel SK; Sarmiento JM; Staley CA; Adsay NV; El-Rayes BF; Weber SM; Winslow ER; Cho CS; Zavala KA; Bentrem DJ; Knab M; Ahmad SA; Abbott DE; Sutton JM; Kim HJ; Yeh JJ; Aufforth R; Scoggins CR; Martin RC; Parikh AA; Robinson J; Hashim YM; Fields RC; Hawkins WG; Merchant NB
    Ann Surg; 2014 Sep; 260(3):494-501; discussion 501-3. PubMed ID: 25115425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.
    Ghaneh P; Kleeff J; Halloran CM; Raraty M; Jackson R; Melling J; Jones O; Palmer DH; Cox TF; Smith CJ; O'Reilly DA; Izbicki JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Padbury R; Shannon J; Dervenis C; Glimelius B; Deakin M; Anthoney A; Lerch MM; Mayerle J; Oláh A; Rawcliffe CL; Campbell F; Strobel O; Büchler MW; Neoptolemos JP;
    Ann Surg; 2019 Mar; 269(3):520-529. PubMed ID: 29068800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Most pancreatic cancer resections are R1 resections.
    Esposito I; Kleeff J; Bergmann F; Reiser C; Herpel E; Friess H; Schirmacher P; Büchler MW
    Ann Surg Oncol; 2008 Jun; 15(6):1651-60. PubMed ID: 18351300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
    Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.
    Markov P; Satoi S; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Sep; 23(9):523-32. PubMed ID: 27524388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    Weyhe D; Obonyo D; Uslar VN; Stricker I; Tannapfel A
    PLoS One; 2021; 16(3):e0248633. PubMed ID: 33735191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Jamieson NB; Chan NI; Foulis AK; Dickson EJ; McKay CJ; Carter CR
    J Gastrointest Surg; 2013 Mar; 17(3):511-21. PubMed ID: 23297028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
    Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
    JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
    Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Raut CP; Tseng JF; Sun CC; Wang H; Wolff RA; Crane CH; Hwang R; Vauthey JN; Abdalla EK; Lee JE; Pisters PW; Evans DB
    Ann Surg; 2007 Jul; 246(1):52-60. PubMed ID: 17592291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?
    Gebauer F; Tachezy M; Vashist YK; Marx AH; Yekebas E; Izbicki JR; Bockhorn M
    World J Surg; 2015 Feb; 39(2):493-9. PubMed ID: 25270344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
    Katou S; Wenning AS; Aeschbacher P; Morgul H; Becker F; Pascher A; Gloor B; Strücker B; Andreou A
    Surgery; 2023 Jul; 174(1):91-99. PubMed ID: 37121858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
    Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival.
    Fatima J; Schnelldorfer T; Barton J; Wood CM; Wiste HJ; Smyrk TC; Zhang L; Sarr MG; Nagorney DM; Farnell MB
    Arch Surg; 2010 Feb; 145(2):167-72. PubMed ID: 20157085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.
    Matthaei H; Hong SM; Mayo SC; dal Molin M; Olino K; Venkat R; Goggins M; Herman JM; Edil BH; Wolfgang CL; Cameron JL; Schulick RD; Maitra A; Hruban RH
    Ann Surg Oncol; 2011 Nov; 18(12):3493-9. PubMed ID: 21537863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma.
    Xiong J; Wei A; Ke N; He D; Chian SK; Wei Y; Hu W; Liu X
    Int J Surg; 2017 Dec; 48():134-141. PubMed ID: 29081373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity.
    De Reuver PR; Mittal A; Neale M; Gill AJ; Samra JS
    Surgery; 2015 Jul; 158(1):183-90. PubMed ID: 25920909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
    van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
    Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.